rs121909590
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_172351.3(CD46):c.175C>T(p.Arg59*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,613,684 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_172351.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- atypical hemolytic-uremic syndrome with MCP/CD46 anomalyInheritance: AD, AR, SD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_172351.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CD46 | NM_172351.3 | MANE Select | c.175C>T | p.Arg59* | stop_gained | Exon 2 of 13 | NP_758861.1 | ||
| CD46 | NM_172359.3 | c.175C>T | p.Arg59* | stop_gained | Exon 2 of 13 | NP_758869.1 | |||
| CD46 | NM_002389.4 | c.175C>T | p.Arg59* | stop_gained | Exon 2 of 14 | NP_002380.3 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CD46 | ENST00000367042.6 | TSL:1 MANE Select | c.175C>T | p.Arg59* | stop_gained | Exon 2 of 13 | ENSP00000356009.1 | ||
| CD46 | ENST00000322875.8 | TSL:1 | c.175C>T | p.Arg59* | stop_gained | Exon 2 of 13 | ENSP00000313875.4 | ||
| CD46 | ENST00000358170.6 | TSL:1 | c.175C>T | p.Arg59* | stop_gained | Exon 2 of 14 | ENSP00000350893.2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152138Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251414 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461546Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 727108 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152138Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74322 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Pathogenic:2
This sequence change creates a premature translational stop signal (p.Arg59*) in the CD46 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CD46 are known to be pathogenic (PMID: 16621965, 23431077). This variant is present in population databases (rs121909590, gnomAD 0.009%). This premature translational stop signal has been observed in individual(s) with hemolytic uremic syndrome (PMID: 16621965, 23780777, 34169201). This variant is also known as R25Stop. ClinVar contains an entry for this variant (Variation ID: 17048). For these reasons, this variant has been classified as Pathogenic.
PP1, PS3_moderate, PS4, PVS1
Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly Pathogenic:1Other:1
Atypical hemolytic-uremic syndrome Pathogenic:1
CD46 p.Arg59Ter (c.175C>T) is a nonsense variant that introduces a premature stop codon at amino acid position 59, creating a truncated protein that is predicted to undergo nonsense-mediated mRNA decay. This variant has been observed in at least one proband affected with atypical hemolytic-uremic syndrome (PMID:27799617;16621965;16762990;33188793;33048203;38317858;26559391;23780777;30916388). The variant was found to segregate with disease in at least one affected family (PMID:16621965). It is absent or not present at a significant frequency in gnomAD. In conclusion, we classify CD46 p.Arg59Ter (c.175C>T) as a pathogenic variant.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at